Neuroendocrine Differentiation and Response to PSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: A Single-Center Retrospective StudyThorsten Derlin, Frank M. Bengel|Journal of Nuclear Medicine|2020Cited by 35
PSMA‐heterogeneity in metastatic castration‐resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapyThorsten Derlin, Frank M. Bengel|The Prostate|2023Cited by 28